Yildiz Atar Hilal, Baatz John E, Ryan Rita M
Departments of Pediatrics (Neonatology), UH Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, OH 44106, USA.
Departments of Pediatrics (Neonatology), Medical University of South Carolina, Charleston, SC 29425, USA.
Children (Basel). 2021 Apr 6;8(4):281. doi: 10.3390/children8040281.
Respiratory distress is a significant contributor to newborn morbidity and mortality. An association between infants of diabetic mothers (IDMs) and respiratory distress syndrome (RDS) has been well recognized for decades. As obesity and diabetes prevalence have increased over the past several decades, more women are overweight and diabetic in the first trimester, and many more pregnant women are diagnosed with gestational diabetes. Glycemic control during pregnancy can be challenging due to the maternal need for higher caloric intake and higher insulin resistance. Surfactant is a complex molecule at the alveolar air-liquid interface that reduces surface tension. Impaired surfactant synthesis is the primary etiology of RDS. In vitro cell line studies, in vivo animal studies with diabetic rat offspring, and clinical studies suggest hyperglycemia and hyperinsulinemia can disrupt surfactant lipid and protein synthesis, causing delayed maturation in surfactant in IDMs. A better understanding of the molecular mechanisms responsible for surfactant dysfunction in IDMs may improve clinical strategies to prevent diabetes-related complications and improve neonatal outcomes.
呼吸窘迫是新生儿发病和死亡的重要原因。几十年来,糖尿病母亲的婴儿(IDM)与呼吸窘迫综合征(RDS)之间的关联已得到充分认识。在过去几十年中,随着肥胖和糖尿病患病率的上升,更多女性在孕早期超重和患有糖尿病,并且有更多孕妇被诊断为妊娠期糖尿病。由于孕妇需要更高的热量摄入和更高的胰岛素抵抗,孕期血糖控制可能具有挑战性。表面活性剂是肺泡气液界面的一种复杂分子,可降低表面张力。表面活性剂合成受损是RDS的主要病因。体外细胞系研究、对糖尿病大鼠后代的体内动物研究以及临床研究表明,高血糖和高胰岛素血症会破坏表面活性剂脂质和蛋白质合成,导致IDM中表面活性剂成熟延迟。更好地了解IDM中表面活性剂功能障碍的分子机制可能会改善预防糖尿病相关并发症的临床策略并改善新生儿结局。